Eli Lilly Web Site To Include Clinical Trial Data for Several Medications
Eli Lilly officials said the company on Wednesday will unveil a Web site that contains results from clinical trials, a registry of ongoing trials, a list of trials recruiting participants and an education section, the Wall Street Journal reports. The site will initially contain results for tests of eight prescription drugs -- including schizophrenia medication Zyprexa, antidepressant Cymbalta and attention deficit hyperactivity disorder treatment Strattera -- and company officials said they hope to have tests for all products on the Web site by mid-2005. Users can search the site by medication or medical condition and find published and unpublished clinical trial results. Lilly officials said the site would contain information about all tests following the completion of Phase I trials. Lilly established the Web site in response to concerns about antidepressant use in children and "pressure to disclose more information about potential health problems and side effects that surface during clinical trials" in the wake of Merck's withdrawal of Vioxx, according to the Journal. The trial results section of the site is "likely to get the most attention" in part because Lilly will publish data from the four stages of clinical trials finished after July and the "core efficacy and safety trials used to get the drug approved" for trials completed earlier, according to the Journal. Company officials said trial results that were contrary to the expected outcome will be posted, as well as trials on unapproved uses of medicines, although not all are on display yet (Abboud, Wall Street Journal, 12/8).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
